These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31393871)

  • 21. Incidence and characteristics of type-2 breaks in response to antitachycardia pacing therapy in implantable cardioverter defibrillator patients.
    Sharma V; DeGroot PJ; Wathen MS
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1156-62. PubMed ID: 14678127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion.
    Bardy GH; Poole JE; Kudenchuk PJ; Dolack GL; Kelso D; Mitchell R
    Circulation; 1993 Jun; 87(6):1889-96. PubMed ID: 8504501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial Clinical Experience With a New Automated Antitachycardia Pacing Algorithm: Feasibility and Safety in an Ambulatory Patient Cohort.
    Yee R; Fisher JD; Birgersdotter-Green U; Smith TW; Kenigsberg DN; Canby R; Jackson T; Taepke R; DeGroot P
    Circ Arrhythm Electrophysiol; 2017 Sep; 10(9):. PubMed ID: 28887360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The benefit of a second burst antitachycardia sequence for fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Anguera I; Dallaglio P; Sabaté X; Nuñez E; Gracida M; Di Marco A; Sugrañes G; Cequier A
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):486-94. PubMed ID: 24215374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies.
    Wathen M
    Am Heart J; 2007 Apr; 153(4 Suppl):44-52. PubMed ID: 17394902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator.
    Tjong FVY; Brouwer TF; Koop B; Soltis B; Shuros A; Schmidt B; Swackhamer B; Quast AEB; Wilde AAM; Burke MC; Knops RE
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1487-1498. PubMed ID: 29759829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basal exit site of clinical ventricular tachycardia is an independent predictor of antitachycardia pacing failure in implantable cardioverter-defibrillators recipients.
    Boulé S; Brigadeau F; Marquié C; Salleron J; Klug D; Kouakam C; Guédon-Moreau L; Duhamel A; Acheré C; Wissocque L; Lacroix D; Kacet S
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1209-16. PubMed ID: 22817404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of anti-tachycardia pacing for terminating fast ventricular tachycardia in Japanese implantable cardioverter defibrillator patients. Primary results of the SATISFACTION study.
    Watanabe T; Inoue K; Kashiwase K; Mine T; Hirooka K; Shutta R; Okuyama Y; Mizuno H; Shimoshige S; Takenaka S; Sumiyoshi T; Yambe Y; Shirota K; Nitta J; Ito M; Keida T; Nanto S
    Circ J; 2014; 78(11):2643-50. PubMed ID: 25262963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging.
    Schoels W; Steinhaus D; Johnson WB; O'hara G; Schwab JO; Jenniskens I; Degroot PJ; Tang F; Helmling E;
    Heart Rhythm; 2007 Jul; 4(7):879-85. PubMed ID: 17599671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of delivered therapy for VT or VF in patients with third-generation implantable cardioverter defibrillators.
    Rabinovich R; Muratore C; Iglesias R; Gonzalez M; Serafrica M; Sosa Liprandi A
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):133-6. PubMed ID: 7724386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term efficacy of antitachycardia pacing for treatment of ventricular tachycardia in patients with implantable cardioverter/defibrillator].
    Fiek M; Hoffmann E; Dorwarth U; Müller D; Steinbeck G
    Z Kardiol; 1999 Oct; 88(10):815-22. PubMed ID: 10552185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of novel intrinsic versus conventional antitachycardia pacing for ventricular tachycardia among implantable cardioverter-defibrillator recipients.
    Yanagisawa S; Inden Y; Sato Y; Watanabe R; Goto T; Kondo S; Tachi M; Iwawaki T; Yamauchi R; Hiramatsu K; Shimojo M; Tsuji Y; Shibata R; Murohara T
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):821-831. PubMed ID: 38424678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial.
    Arenal A; Proclemer A; Kloppe A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Europace; 2016 Nov; 18(11):1719-1725. PubMed ID: 27485577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antitachycardia pacing in patients with implanted cardioverter defibrillators].
    Ardashev AV; Dzhandzhgava AO; Zheliakov EG
    Kardiologiia; 2011; 51(1):65-73. PubMed ID: 21626805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized cross-over evaluation of two adaptive pacing algorithms for the termination of ventricular tachycardia.
    Kantoch MJ; Green MS; Tang AS
    Pacing Clin Electrophysiol; 1993 Aug; 16(8):1664-72. PubMed ID: 7690935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct comparison of a novel antitachycardia pacing algorithm against present methods using virtual patient modeling.
    Swenson DJ; Taepke RT; Blauer JJE; Kwan E; Ghafoori E; Plank G; Vigmond E; MacLeod RS; DeGroot P; Ranjan R
    Heart Rhythm; 2020 Sep; 17(9):1602-1608. PubMed ID: 32438017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
    Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
    J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of burst versus ramp antitachycardia pacing therapy for ventricular tachycardia: A meta-analysis.
    de Sousa MR; Cota GF; Burger AL; Pezawas T
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):842-850. PubMed ID: 33484214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of ventricular and supraventricular tachycardias based on the analysis of the first postpacing interval after sequential anti-tachycardia pacing in implantable cardioverter-defibrillator patients.
    Arenal A; Ortiz M; Peinado R; Merino JL; Quesada A; Atienza F; Alberola AG; Ormaetxe J; Castellanos E; Rodriguez JC; Pérez N; García J; Boluda L; del Prado M; Artés A
    Heart Rhythm; 2007 Mar; 4(3):316-22. PubMed ID: 17341396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.